# Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study

> **NCT05963646** · — · COMPLETED · sponsor: **Institute of Molecular and Clinical Ophthalmology Basel** · enrollment: 30 (actual)

## Conditions studied

- Age-Related Macular Degeneration
- Geographic Atrophy
- Visual Field Defect, Central Scotoma of Both Eyes

## Interventions

- **DIAGNOSTIC_TEST:** Natural history study

## Key facts

- **NCT ID:** NCT05963646
- **Lead sponsor:** Institute of Molecular and Clinical Ophthalmology Basel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-16
- **Primary completion:** 2023-06-23
- **Final completion:** 2023-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05963646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05963646, "Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05963646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
